Login / Signup
Tae-Bin Yim
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 2
Top Topics
Preterm Infants
Cognitive Impairment
Phase Ii
Placebo Controlled
Top Venues
Evidence-based complementary and alternative medicine : eCAM
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Ha-Ri Kim
,
Hee-Yeon Shin
,
Tae-Bin Yim
,
Geon Ho Jahng
,
Chul Jin
,
Seungwon Kwon
,
Seung-Yeon Cho
,
Seong-Uk Park
,
Woo-Sang Jung
,
Sang-Kwan Moon
,
Chang-Nam Ko
,
Jung-Mi Park
Efficacy of Kami Guibi-tang as an Add-On Therapy to Acetylcholinesterase Inhibitor for Cognitive Function in Mild Alzheimer's Disease: A Pilot Study.
Evidence-based complementary and alternative medicine : eCAM
2023 (2023)
Ha-Ri Kim
,
Hee-Yeon Shin
,
Tae-Bin Yim
,
Geon Ho Jahng
,
Chul Jin
,
Seungwon Kwon
,
Seung-Yeon Cho
,
Seong-Uk Park
,
Woo-Sang Jung
,
Sang-Kwan Moon
,
Chang-Nam Ko
,
Jung-Mi Park
Efficacy of Kami Guibi-tang as an Add-On Therapy to Acetylcholinesterase Inhibitor for Cognitive Function in Mild Alzheimer's Disease: A Pilot Study.
Evidence-based complementary and alternative medicine : eCAM
2023 (2023)